Ruth S Nussenzweig

This inventor holds 9 USPTO granted patents. Top assignees: New York University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1984-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth S Nussenzweig. Retrieved from https://idiyas.com/inventor/ruth-s-nussenzweig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 77.8

Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 122(Granted Patents)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1984-2015

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9096653 - Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia (2015-08-04),

2. 8444996 - Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia (2013-05-21),

3. 5700906 - Immunogenic peptide antigen corresponding to plasmodium vivax (1997-12-23),

4. 5614194 - Protective peptide antigen (1997-03-25),

5. 5219730 - Idiotype-anti-idiotype immunoassay (1993-06-15),

6. 5178861 - Cross-reactive and protective epitopes of circumsporozoite proteins (1993-01-12),

7. 4957869 - Immunogenic peptide corresponding to P. vivax CS protein (1990-09-18),

8. 4915942 - Cross-reactive and protective epitopes of CS (1990-04-10),

9. 4466917 - Malaria vaccine (1984-08-21),

Title: Ruth S. Nussenzweig: A Pioneer in Malaria Vaccine Development

Introduction

Ruth S. Nussenzweig is a prominent inventor known for her significant contributions to the field of immunology and vaccine development. Based in New York, NY, she holds a total of nine patents, showcasing her innovative work in combating malaria. Her research has focused on creating effective vaccines that provide long-lasting immune responses against the malaria-causing plasmodia.

Latest Patents

One of her latest patents involves a multicomponent vaccine for malaria that elicits an immune response to specific proteins. This patent discloses immunogenic conjugates that target sexual stage surface proteins and the circumsporozoite protein (CSP). The immunogenic compositions include these conjugates along with a pharmaceutically acceptable carrier. Additionally, the patent outlines a method for eliciting an immune response in a subject by administering the disclosed immunogenic composition.

Career Highlights

Ruth S. Nussenzweig has had a distinguished career, working with esteemed institutions such as New York University and the National Institutes of Health, which is a component of the U.S. Department of Health & Human Services. Her work has been instrumental in advancing the understanding and treatment of malaria through innovative vaccine research.

Collaborations

Throughout her career, Nussenzweig has collaborated with notable colleagues, including Victor N. Nussenzweig and G. Nigel Godson. These collaborations have further enriched her research and contributed to the development of effective malaria vaccines.

Conclusion

Ruth S. Nussenzweig's contributions to malaria vaccine development have made her a key figure in the field of immunology. Her innovative patents and collaborations reflect her dedication to improving public health through scientific research.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]